Dr. Ravi Amaravadi, a clinical oncologist specializing in the role of autophagy in cancer therapy and scientific advisor to Sprint Bioscience, was invited to us in Stockholm to contribute his clinical expertise. Autophagy is an area of cancer therapy that has received attention recently, and the meeting included discussions on the latest findings in clinical studies in this field.
Dr. Ravi Amaravadi is active at the Abramson Cancer Center, University of Pennsylvania.
